NEW HOPE, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A leadless pacing-defibrillator system was safe and met ...
Clinical study evaluated impact of AVIM therapy as compared to standard pacing using invasive pressure-volume loop analysis in 16 hypertensive pacemaker-indicated patients Results demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results